Kotak 
Dealstreet

Kotak PE invests 400 crore in Biorad Medisys: Luthra advises

Kotak Strategic Situations India Fund II invested ₹400 crore.

Bar & Bench

Kotak Strategic Situations India Fund II, managed by Kotak Alternate Asset Managers Limited, has made an investment of up to ₹400 Crore in medical device manufacturer Biorad Medisys Private Limited.

Luthra and Luthra Law Offices India represented Kotak in this investment deal.

The transaction team consisted of Nishant Singh (Partner), Prachi Pandit (Managing Associate), Saksham Madan (Managing Associate), Manushi Shah (Associate), Varshini Ramesh (Associate), Aditi Nagpal (Associate), Charith Reddy (Associate), Kashish Singhal (Associate), Maitri Meghani (Associate) and Aashi Shah (Associate).

Nishant Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Trilegal, CAM, SAM, Khaitan and JSA dominate India’s IPO market in 2024–25

Delhi High Court places trial judge under suspension, initiates disciplinary proceedings

Supreme Court questions P&H High Court for delay in publishing order, directs probe into backdated order

Article 21 must extend to preservation of ecological conditions essential for life: Justice Surya Kant

Recipe for trouble: Delhi court restrains FoodInfotech from copying FoodTechBiz's content

SCROLL FOR NEXT